Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04655976
Title Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants (COSTAR Lung)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Docetaxel + Dostarlimab-gxly + TSR-022

Docetaxel + Dostarlimab-gxly

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Recruiting Whittier California 90603 United States Details
GSK Investigational Site Recruiting Norwich Connecticut 06360 United States Details
GSK Investigational Site Recruiting White Plains New York 10601 United States Details
GSK Investigational Site Recruiting Sioux Falls South Dakota 57105 United States Details
GSK Investigational Site Recruiting Blacktown New South Wales 2148 Australia Details
GSK Investigational Site Recruiting Kurralta Park South Australia 5037 Australia Details
GSK Investigational Site Recruiting South Brisbane South Australia 4101 Australia Details
GSK Investigational Site Recruiting Hobart Tasmania 7000 Australia Details
GSK Investigational Site Recruiting Ballarat Victoria 3350 Australia Details
GSK Investigational Site Recruiting Grenoble cedex 9 38043 France Details
GSK Investigational Site Recruiting Quimper cedex 29107 France Details
GSK Investigational Site Recruiting Rennes Cedex 9 35033 France Details
GSK Investigational Site Recruiting Tours cedex 9 37044 France Details
GSK Investigational Site Recruiting Frankfurt Hessen 60488 Germany Details
GSK Investigational Site Recruiting Avellino Campania 83100 Italy Details
GSK Investigational Site Recruiting Napoli Campania 80131 Italy Details
GSK Investigational Site Recruiting Orbassano (TO) Piemonte 10043 Italy Details
GSK Investigational Site Recruiting Firenze Toscana 50134 Italy Details
GSK Investigational Site Recruiting Cheongju-si, Chungcheongbuk-do 28644 Korea, Republic of Details
GSK Investigational Site Recruiting Gyeonggi-do 10408 Korea, Republic of Details
GSK Investigational Site Recruiting Seongnam-si, Gyeonggi-do 13620 Korea, Republic of Details
GSK Investigational Site Recruiting Seoul 03722 Korea, Republic of Details
GSK Investigational Site Recruiting Seoul 05505 Korea, Republic of Details
GSK Investigational Site Recruiting Seoul 06351 Korea, Republic of Details
GSK Investigational Site Recruiting Bydgoszcz 85-796 Poland Details
GSK Investigational Site Recruiting Gdynia 81-519 Poland Details
GSK Investigational Site Recruiting Olsztyn 10-357 Poland Details
GSK Investigational Site Recruiting Ostroleka 07-410 Poland Details
GSK Investigational Site Recruiting Pila 64-920 Poland Details
GSK Investigational Site Recruiting Poznan 60-693 Poland Details
GSK Investigational Site Recruiting Chelyabinsk 454048 Russian Federation Details
GSK Investigational Site Recruiting Pushkin 196603 Russian Federation Details
GSK Investigational Site Recruiting Saint-Petersburg 197022 Russian Federation Details
GSK Investigational Site Recruiting Barcelona 08036 Spain Details
GSK Investigational Site Recruiting La Coruña 15006 Spain Details
GSK Investigational Site Recruiting Madrid 28034 Spain Details
GSK Investigational Site Recruiting Madrid 28050 Spain Details
GSK Investigational Site Recruiting Majadahonda (Madrid) 28222 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field